Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature

Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver conditions, and its progression is marked by evolution to non-alcoholic steatosis, steatohepatitis, cirrhosis related to non-alcoholic steatohepatitis, and the potential occurrence of hepatocellular carcinoma. In our...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2024-04, Vol.25 (8), p.4201
Hauptverfasser:	Ionita-Radu, Florentina, Patoni, Cristina, Nancoff, Andreea Simona, Marin, Flavius-Stefan, Gaman, Laura, Bucurica, Ana, Socol, Calin, Jinga, Mariana, Dutu, Madalina, Bucurica, Sandica
Format:	Artikel
Sprache:	eng
Schlagworte:	Amino acids Animals Berberine - pharmacology Berberine - therapeutic use Biopsy Blood lipids Diabetes Enzymes Fatty liver Humans Inflammation Liver - drug effects Liver - metabolism Liver - pathology Liver cancer Liver cirrhosis Liver Cirrhosis - drug therapy Liver Cirrhosis - metabolism Liver Cirrhosis - pathology Liver diseases Medical research Medicine, Experimental Metabolism Metabolites Non-alcoholic Fatty Liver Disease - drug therapy Non-alcoholic Fatty Liver Disease - metabolism Non-alcoholic Fatty Liver Disease - pathology Obesity Protein kinases Spectrum analysis Type 2 diabetes Ultrasonic imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!